Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nitric Oxide in Right Ventricular Dysfunction: Improvements in Clinical and Hemodynamic Parameters on Venoarterial Extracorporeal Membrane Oxygenation (VA-ECMO; NOVICE)

NCT04224103 is registered in ClinicalTrials.gov with Filio Billia as lead sponsor.

NCT NCT04224103
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04224103 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nitric Oxide in Right Ventricular Dysfunction: Improvements in Clinical and Hemodynamic Parameters on Venoarterial Extracorporeal Membrane Oxygenation (VA-ECMO; NOVICE)
Lead sponsor
Filio Billia
Phase
Observational
Overall status
Unknown status
Start date
August 8, 2019
Completion date
February 28, 2022
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

extracorporeal membrane oxygenation, nitric oxide, shock, cardiogenic